Spondylarthropathies: Clinical Trials

1,160 trials for Spondylarthropathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

660 completed, 155 unknown, 128 recruiting, 63 not yet recruiting. 227 Not applicable, 205 Phase 3, 131 Phase 2, 120 Phase 4, 50 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable227Completed 117, Unknown 39, Recruiting 29, Not yet recruiting 19, Active not recruiting 11, Terminated 4, Withdrawn 4, Enrolling by invitation 2, Suspended 2
Phase 3205Completed 150, Active not recruiting 19, Terminated 11, Unknown 9, Recruiting 8, Not yet recruiting 4, Withdrawn 3, Enrolling by invitation 1
Phase 2131Completed 61, Unknown 22, Terminated 21, Recruiting 11, Not yet recruiting 6, Withdrawn 5, Active not recruiting 4, Enrolling by invitation 1
Phase 4120Completed 64, Unknown 19, Recruiting 13, Withdrawn 7, Not yet recruiting 6, Terminated 6, Active not recruiting 4, Enrolling by invitation 1
Phase 150Completed 25, Recruiting 8, Terminated 6, Not yet recruiting 5, Unknown 3, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Early Phase 16Unknown 3, Completed 1, Terminated 1, Withdrawn 1

Follow Spondylarthropathies: new trials by email Literature Review of Spondylarthropathies trials Research Report on Spondylarthropathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
DDY391 - Moderate to Severe Psoriatic Arthritis
Phase 2Not yet recruitingNovartis Pharmaceuticals882027-02-102026-11-06
A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt)
Placebo, Zasocitinib - Psoriatic Arthritis
Phase 3Not yet recruitingTakeda6442027-01-112026-10-27
Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis
Patient-Reported Outcomes Dashboard With Goal Setting - Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA)
Not applicableNot yet recruitingNorthwestern University1602027-01-012026-10-15
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
Deucravacitinib - Systemic Lupus Erythematosus, Sjögren's Disease
Phase 3Not yet recruitingBristol-Myers Squibb23002026-12-312026-09-03
Apremilast and Adalimumab in Psoriatic Arthritis Patients
Adalimumab, Apremilast - Psoriatic Arthritis, Ultrasound Assessment
Not applicableNot yet recruitingTanta University602026-12-302026-09-08
Phase 2 Trial of FT2109 for the Treatment of Psoriatic Arthritis
FT2109 Dosing Regimen 1, FT2109 Dosing Regimen 2, Matching Placebo - Psoriatic Arthritis (PsA)
Phase 2Not yet recruitingForward Therapeutics2102026-12-012026-10-09
Effects of Land- and Water-Based Exercise in Axial Spondyloarthritis
Land-Based Combined Exercise Program, Aquatic Combined Exercise Program, Home Exercise Program - Axial Spondyloarthritis and Ankylosing Spondylitis
Not applicableNot yet recruitingIzmir University of Economics502026-12-012026-09-22
Remote Monitoring in Young Adults With Inflammatory Joint Disease
Remote digital follow-up, Conventional hospital-based follow-up - Rheumatoid Arthritis (RA, Juvenile Idiopathic Arthritis (JIA)
Not applicableNot yet recruitingDiakonhjemmet Hospital1482026-12-012026-11-16
Phase Ia Study of MST-931 in Healthy Adult Subjects
MST-931, MST-931 Placebo - Ankylosing Spondylitis (AS)
Phase 1RecruitingMabsoft Therapeutics (Shanghai) Co., Ltd.322026-11-302026-11-03
Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release Formulation
Apremilast XR, Apremilast IR - Psoriasis, Arthritis, Psoriatic
Phase 1RecruitingAmgen1142026-11-182026-11-20
Postural Biofeedback and Exercise in Axial Spondyloarthritis
Standard Exercise Program, Wearable Postural Biofeedback - Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis (AS)
Not applicableRecruitingIstanbul University - Cerrahpasa382026-11-172026-11-20
Scapular Mobilization Added to Conventional Exercise in Ankylosing Spondylitis
Scapular Mobilization, Conventional Exercise Program - Ankylosing Spondylitis, Axial Spondyloarthritis
Not applicableNot yet recruitingIzmir Bakircay University342026-11-162026-11-18
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Bedside quantitative sensory testing - Rheumatic Diseases, Lupus Erythematosus, Systemic
RecruitingNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2252026-11-092026-11-19
A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
Secukinumab (IL-17i ), Upadacitinib (JAKi) - Axial Spondyloarthritis (AxSpA)
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston402026-11-012026-10-14
Posture Exercises in Ankylosing Spondylitis
Standard Breathing Exercise Program, Posture-Focused Exercise Program - Ankylosing Spondylitis (AS)
Not applicableNot yet recruitingMustafa Akça542026-11-012026-10-16
A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis
GKL-006Allo - Ankylosing Spondylitis
Phase 1Not yet recruitingBeijing Gene Key Life Technology Co., Ltd122026-11-012026-11-04
Allogeneic iNKT Cells in AS: Immune Remodeling Study
Allogeneic iNKT Cells - Ankylosing Spondylitis
Not yet recruitingChinese PLA General Hospital122026-11-012026-11-20
SLAMF1 Gene Expression in Ankylosing Spondylitis
Ankylosing Spondylitis
Not yet recruitingAssiut University1002026-10-302026-10-30
Corrective Spinal Surgery for Severe Spinal Curvature in People With Ankylosing Spondylitis
pedicle subtraction osteotomy - Ankylosing Spondylitis
Not applicableNot yet recruitingChina-Japan Friendship Hospital352026-10-302026-11-12
Ivarmacitinib With or Without Celecoxib for Ankylosing Spondylitis
Ivarmacitinib with celecoxib, Ivarmacitinib Monotherapy - Ankylosing Spondylitis (AS)
Phase 4Not yet recruitingPeking University Third Hospital1382026-10-252026-10-27

Showing 20 of 1160. Sign in to see all of them.

Narrower conditions

Arthritis, Psoriatic (597)  ·  Spondylitis, Ankylosing (526)  ·  Arthritis, Rheumatoid (236)  ·  Axial Spondyloarthritis (179)  ·  Psoriasis (141)  ·  Spondylarthritis (95)  ·  Arthritis (81)  ·  Crohn Disease (61)  ·  Colitis, Ulcerative (46)  ·  Lupus Erythematosus, Systemic (39)  ·  Non-Radiographic Axial Spondyloarthritis (32)  ·  Inflammatory Bowel Diseases (26)  ·  Motor Activity (26)  ·  Arthritis, Juvenile (24)

Broader conditions

Bone Diseases (1158)  ·  Spinal Diseases (1153)  ·  Musculoskeletal Diseases (1152)  ·  Joint Diseases (1145)  ·  Spondylitis (1136)  ·  Arthritis (1079)  ·  Spondylarthritis (1065)  ·  Skin and Connective Tissue Diseases (672)  ·  Ankylosis (654)  ·  Skin Diseases, Papulosquamous (608)  ·  Skin Diseases (607)  ·  Axial Spondyloarthritis (477)  ·  Psoriasis (469)  ·  Immune System Diseases (265)

Interventions

Etanercept (74)  ·  Adalimumab (69)  ·  secukinumab (58)  ·  Infliximab (50)  ·  Methotrexate (34)  ·  golimumab (34)  ·  apremilast (26)  ·  bimekizumab (21)  ·  tofacitinib (20)  ·  Ustekinumab (19)  ·  guselkumab (18)  ·  ixekizumab (18)  ·  Certolizumab Pegol (15)  ·  Surveys and Questionnaires (14)  ·  upadacitinib (14)

Sponsors

Novartis Pharmaceuticals (48)  ·  Pfizer (38)  ·  AbbVie (36)  ·  Amgen (24)  ·  Janssen Research & Development, LLC (23)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (21)  ·  Charite University, Berlin, Germany (18)  ·  UCB Biopharma SRL (18)  ·  Merck Sharp & Dohme LLC (17)  ·  Assistance Publique - Hôpitaux de Paris (16)  ·  AbbVie (prior sponsor, Abbott) (14)  ·  Eli Lilly and Company (13)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (13)  ·  Bristol-Myers Squibb (12)  ·  Diakonhjemmet Hospital (12)

Countries

United States (273)  ·  Germany (183)  ·  France (172)  ·  United Kingdom (145)  ·  Spain (140)  ·  Canada (138)  ·  Turkey (Türkiye) (130)  ·  Poland (128)  ·  China (119)  ·  Czechia (114)  ·  Russia (93)  ·  Hungary (92)  ·  Belgium (91)  ·  Italy (89)  ·  Australia (78)

Top investigators

Joachim Sieper, MD (6)  ·  Lai Shan Tam, MD (4)

Results publications

PMID 40194794, PMID 41807031, PMID 31203228, PMID 37316690, PMID 38446397, PMID 41965705, PMID 42386286, PMID 34618347, PMID 35305260, PMID 38488975, PMID 38488976, PMID 39120849, PMID 30473179, PMID 33722947, PMID 34795065, PMID 35393269, PMID 36178584, PMID 36642439, PMID 36792107, PMID 37906417, PMID 37982966, PMID 38683479, PMID 39120848, PMID 39624020, PMID 40241921, PMID 40875187, PMID 41039829, PMID 19297344, PMID 30018799, PMID 30739254, PMID 31077258, PMID 31112005, PMID 31909868, PMID 31964419, PMID 32006348, PMID 32352653, PMID 32816215, PMID 33227175, PMID 33351179, PMID 34536218, PMID 34773130, PMID 34870800, PMID 35429281, PMID 36058784, PMID 36282526, PMID 36526796, PMID 36754548, PMID 36931693, PMID 36958766, PMID 36995469

NIH funding

2015 (18), 2016 (16), 2023 (16), 2017 (14), 2009 (13), 2014 (11), 2018 (10), 2019 (9), 2025 (6), 2008 (4), 2005 (3), K08CA237619 (1), K23HL152013 (1), KL2TR003168 (1), P20GM130414 (1)